Candel Therapeutics, Inc.CADLNASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
-13.7%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 30.80% |
| 2024 | -45.44% |
| 2023 | -101.87% |
| 2022 | 47.97% |
| 2021 | -104.32% |
| 2020 | -114.56% |
| 2019 | 0.00% |